Considering that heart disease is the #1 cause of death in the developed world, anything that can prevent cardiac mortality, or slow or even reverse the cardiovascular disease process, should be of great interest to the general public.
Sadly, millions of folks are unaware of the extensive body of biomedical literature that exists supporting the use of natural compounds for preventing and even reversing heart disease.
Instead, they spend billions buying highly toxic cholesterol-lowering pharmaceuticals with known cardiotoxicity, among 300 other proven side effects, simply because their doctor told them to do so.
So, with this in mind, let’s look at the biomedical literature itself.
3 Natural Substances that Reduce the Risk of Heart-Related Death
Omega-3 Fatty Acids: There is a robust body of research indicating that the risk of sudden cardiac death is reduced when consuming higher levels of omega-3 fatty acids. Going all the way back to 2002, the New England Journal of Medicine published a study titled, ”Blood levels of long-chain n-3 fatty acids and the risk of sudden death,” which found “The n-3 fatty acids found in fish are strongly associated with a reduced risk of sudden death among men without evidence of prior cardiovascular disease.” Another 2002 study, published in the journal Circulation, found that Omega-3 fatty acid supplementation reduces total mortality and sudden death in patients who have already had a heart attack.[i] For additional research, view GreenMedInfo’s dataset on the topic of Omega-3 fatty acids and the reduction of cardiac mortality.
It should be noted that the best-selling cholesterol drug class known as statins may actually reduce the effectiveness of omega-3 fats at protecting the heart. This has been offered as an explanation as to why newer research seems to show that consuming omega-3 fats does not lower the risk of cardiac mortality.
Vitamin D: Levels of this essential compound have been found to be directly associated with the risk of dying from all causes. Being in the lowest 25% percent of vitamin D levels is associated with a 26% increased rate of all-cause mortality.[ii] It has been proposed that doubling global vitamin D levels could significantly reduce mortality.[iii] Research published in the journal Clinical Endocrinology in 2009 confirmed that lower vitamin D levels are associated with increased all-cause mortality but also that the effect is even more pronounced with cardiovascular mortality.[iv] This finding was confirmed the same year in the Journal of the American Geriatric Society, [v] and again in 2010 in the American Journal of Clinical Nutrition.[vi]
Magnesium: In a world gone mad over taking inorganic calcium supplementation for invented diseases such as T-score defined “osteopenia” or “osteoporosis,” despite their well-known association with increased risk of cardiac mortality, magnesium’s role in protecting against heart disease cannot be overstressed. It is well-known that even the accelerated aging of the heart muscle experienced by those in long space flight is due to magnesium deficiency. In 2010, the Journal of Biomedical Sciences reported that cardiovascular risks are significantly lower in individuals who excrete higher levels of magneiusm, indicating its protective role.[vii] Another study published in the journal Atherosclerosis in 2011 found that low serum magnesium concentrations predict cardiovascular and all-cause mortality.[viii] Remember that when you are looking to ‘supplement’ your diet with magnesium go green. Chlorophyll is green because it has a magnesium atom at its center. Kale, for example, is far better a source of complex nutrition than magnesium supplements. But, failing the culinary approach, magnesium supplements can be highly effective at attaining a therapeutic and/or cardioprotective dose.
dailyalternative | alternative news – 7 Ways To Prevent and Even Reverse Heart Disease With Nutrition
Google Now Has Access To Millions of Patients’ Medical Records
A controversial deal between tech giant Google and the National Health Service (NHS) will allow artificial intelligence units access to 1.6 million confidential medical records. Since 2014, Google has partnered with several scientists in an attempt to understand human health, but a new report reveals the data gathering goes far beyond what was originally anticipated.
According to documents obtained by the New Scientist, the data sharing agreement between Google-owned artificial intelligence company DeepMind and the Royal Free NHS Trust gives access to the sensitive healthcare data of millions of NHS patients. The chilling and wide-reaching deal allows DeepMind access to the medical records of the 1.6 million people passing annually through the three London hospitals owned by the Trust — Barnet, Chase Farm, and the Royal Free.
The Google-owned A.I. firm announced in February it was working with the NHS to build an app called Streams — intended to help hospitals monitor patients with kidney disease. However, the new information has revealed that the extent of the data being shared goes much further and includes logs of day-to-day hospital activity, records of the location and status of patients, and even logs of who visits them and when.
Results of pathology and radiology tests are also shared, as is information from critical care and accident and emergency departments. In addition, DeepMind’s access to the centralised records of all NHS hospital treatments in the U.K. means the tech company can access historical data from the last five years, all while receiving a continuous stream of new data.
At the same time, DeepMind is developing a platform called Patient Rescue, which uses hospital data streams to build tools to carry out analysis and support diagnostic decisions. The New Scientist explained how it works:
Comparing a new patient’s information with millions of other cases, Patient Rescue might be able to predict that they are in the early stages of a disease that has not yet become symptomatic, for example. Doctors could then run tests to see if the prediction is correct.
While the Royal Free has not yet responded to the question of what — if any — opt-out mechanisms are available to patients, the New Scientist suggests this is unlikely to be a straightforward process. Despite the agreement stating Google cannot use the data in any other part of the company’s business, many will be seriously wary of the access the online tech giant now has to the confidential data of millions of people.
As the New Scientist wrote:
Data mining is the name of the game in the burgeoning field of machine learning and artificial intelligence, and there’s no company in the world better at that than Google.
daily alternative | alternative news – Google Now Has Access To Millions of Patients’ Medical Records
Latest Crypto Price
|Quotes delayed up to 3 minutes.|